Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs UNICHEM LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA UNICHEM LAB GSK PHARMA/
UNICHEM LAB
 
P/E (TTM) x 62.1 239.7 25.9% View Chart
P/BV x 18.8 1.4 1,307.8% View Chart
Dividend Yield % 1.7 0.0 -  

Financials

 GSK PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
UNICHEM LAB
Mar-23
GSK PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs1,684467 360.5%   
Low Rs1,231226 544.6%   
Sales per share (Unadj.) Rs191.9190.7 100.6%  
Earnings per share (Unadj.) Rs35.9-28.7 -124.9%  
Cash flow per share (Unadj.) Rs39.8-12.6 -315.2%  
Dividends per share (Unadj.) Rs32.000-  
Avg Dividend yield %2.20-  
Book value per share (Unadj.) Rs102.9344.2 29.9%  
Shares outstanding (eoy) m169.4170.41 240.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.61.8 417.9%   
Avg P/E ratio x40.6-12.1 -336.8%  
P/CF ratio (eoy) x36.7-27.5 -133.4%  
Price / Book Value ratio x14.21.0 1,406.9%  
Dividend payout %89.20-   
Avg Mkt Cap Rs m246,85824,396 1,011.9%   
No. of employees `000NANA-   
Total wages/salary Rs m5,9503,564 166.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,51713,430 242.1%  
Other income Rs m1,007385 261.4%   
Total revenues Rs m33,52413,815 242.7%   
Gross profit Rs m8,033-841 -954.9%  
Depreciation Rs m6581,134 58.0%   
Interest Rs m18173 10.5%   
Profit before tax Rs m8,364-1,764 -474.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,288259 884.4%   
Profit after tax Rs m6,076-2,022 -300.5%  
Gross profit margin %24.7-6.3 -394.4%  
Effective tax rate %27.4-14.7 -186.5%   
Net profit margin %18.7-15.1 -124.1%  
BALANCE SHEET DATA
Current assets Rs m24,94315,885 157.0%   
Current liabilities Rs m13,2646,396 207.4%   
Net working cap to sales %35.970.7 50.8%  
Current ratio x1.92.5 75.7%  
Inventory Days Days9751 189.9%  
Debtors Days Days2161,600 13.5%  
Net fixed assets Rs m6,98815,911 43.9%   
Share capital Rs m1,694141 1,203.1%   
"Free" reserves Rs m15,73524,092 65.3%   
Net worth Rs m17,43024,233 71.9%   
Long term debt Rs m0636 0.0%   
Total assets Rs m31,93031,829 100.3%  
Interest coverage x462.6-9.2 -5,035.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.00.4 241.4%   
Return on assets %19.1-5.8 -328.5%  
Return on equity %34.9-8.3 -417.8%  
Return on capital %48.1-6.4 -752.0%  
Exports to sales %069.7 0.0%   
Imports to sales %48.112.4 386.9%   
Exports (fob) Rs mNA9,366 0.0%   
Imports (cif) Rs m15,6301,669 936.7%   
Fx inflow Rs m1,6229,366 17.3%   
Fx outflow Rs m15,6301,669 936.7%   
Net fx Rs m-14,0087,697 -182.0%   
CASH FLOW
From Operations Rs m4,842-851 -569.1%  
From Investments Rs m8,0792,028 398.3%  
From Financial Activity Rs m-15,433-813 1,898.3%  
Net Cashflow Rs m-2,512746 -337.0%  

Share Holding

Indian Promoters % 0.0 70.2 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 11.6 11.3 102.4%  
FIIs % 2.9 0.8 348.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 29.8 83.9%  
Shareholders   114,663 20,877 549.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GSK Pharma vs Unichem Lab

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs Unichem Lab Share Price Performance

Period GSK Pharma Unichem Lab S&P BSE HEALTHCARE
1-Day 3.05% 3.46% 1.18%
1-Month -9.96% -3.95% -0.75%
1-Year 52.31% 80.86% 61.82%
3-Year CAGR 10.81% 16.65% 18.16%
5-Year CAGR 8.40% 20.24% 19.79%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the Unichem Lab share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of Unichem Lab the stake stands at 70.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of Unichem Lab.

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 89.2%.

Unichem Lab paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of Unichem Lab.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.